Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

After Mexican Marketing Deal, Korea's Boryung Ventures Into Central And South America

This article was originally published in PharmAsia News

Executive Summary

SEOUL - Following a similar deal with Mexico-based Stendhal International in January, Boryung Pharmaceutical Co. said it is close to signing marketing agreements for its angiotensin receptor blocker Kanarb (fimasartan) in 12 other Central and South American countries
Advertisement

Related Content

Korea’s Boryung Licenses Hypertension Therapy Kanarb To China’s Harbin Gloria
Boryung Pharma And Fellow Korean Firms Sign A Handful Of Overseas Deals – Bio Korea 2013
Korea's Boryung Takes Hypertension Drug Kanarb Beyond Korea With Stendhal Deal
Korea's Boryung Takes Hypertension Drug Kanarb Beyond Korea With Stendhal Deal
Korea's Boryung Pharma Seeking MNCs To Sell Hypertension Product Abroad
South Korean Pharmas Clamber For Partnerships To Survive Rapidly Changing Environment
Advertisement
UsernamePublicRestriction

Register

SC079012

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel